Darusentan in resistant hypertension

Links shared publicly online about this topic.

  • 2,135
    total visits

Darusentan in resistant hypertension

theheart.org

The first of two phase 3 trials with a new endothelin receptor antagonist, darusentan, has shown promise in patients with resistant hypertension, the company reports.

View full resource at theheart.org

Tags: Heart Disease, High Blood Pressure, Phase 3 Clinical Trial, Darusentan

  • Share

Most Recently Shared on April 6, 2009 at 10:34 pm By:

theheartorg Shelley Wood

heartwire Darusentan encouraging in hard-to-treat hypertensives http://tinyurl.com/ctz2jp

3 years ago...

Renal-nerve denervation to combat resistant hypertension

blogs.theheart.org — “With medical treatment of hypertension yielding such limited results, the promise of a safe procedure with robust results is alluring.View full resource at blogs.theheart.org

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 11:30 pm By:

CPAP Can Help With Metabolic Syndrome | Doctor Steven Y. Park, MD | New York, NY | Integrative Solutions for Obstructive Sleep Apnea, Upper Airway Resistance Syndrome, and Snoring

doctorstevenpark.com — “CPAP Can Help With Metabolic SyndromeView full resource at doctorstevenpark.com

  • View Related
  • Share

Most Recently Shared on December 17, 2011 at 7:43 am By:

Resistant High Blood Pressure - Taking Control Of Treatment- | PowerOverPressure

poweroverpressure.com — “High blood pressure, also known as hypertension, is the single most common contributor to death worldwide . Power Over Pressure was developed by a team of global experts in hypertension. Go to our website for more information on high blood pressure.View full resource at poweroverpressure.com

  • View Related
  • Share

Most Recently Shared on December 4, 2011 at 8:55 pm By:

Renal Fellow Network: Resistant Hypertension: breaking the barrier

renalfellow.blogspot.com — “Renal Fellow Network: Resistant Hypertension: breaking the barrierView full resource at renalfellow.blogspot.com

  • View Related
  • Share

Most Recently Shared on October 8, 2011 at 5:37 pm By:

kidneynotes Kidney Notes Health News Feed

RenalFellowNetwork: Resistant Hypertension: breaking the barrier http://t.co/APpM7J8S

6 months ago...

Cinnamaldehyde protects from the hypertension associated with type 1 and type 2 diabetes. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine

greenmedinfo.com — “This article on GreenMedInfo.com concerns - Cinnamaldehyde protects from the hypertension associated with diabetes.View full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on August 20, 2011 at 10:14 pm By:

MedWire News - Cardiology - Clinical characteristics can identify untreated hypertensive patients

medwire-news.md — “MedWire News Doctors may be able to use certain clinical characteristics to help identify and improve the care of patients with untreated, under-treated, or treatment-resistant hypertension, researchers report. MedWire NewsView full resource at medwire-news.md

  • View Related
  • Share

Most Recently Shared on August 15, 2011 at 2:43 pm By:

First renal denervation with Medtronic Symplicity Catheter System performed in Latin America

news-medical.net — “Medtronic today announced the first use in Latin America of renal denervation with the Medtronic Symplicity Catheter System™ to treat a patient with resistant hypertension, which is defined as high blood pressure despite treatment with three or more anti-hypertensive medications. Hypertension is an especially dangerous disease affecting hundreds of millions of people worldwide.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 11:30 am By:

Stroke_News News-Medical.Net Health News

Stroke News: First renal denervation with Medtronic Symplicity Catheter System performed in Latin America: Med... http://twurl.nl/nttn6q

8 months ago...

Untitled

dl.dropbox.com — “UntitledView full resource at dl.dropbox.com

  • View Related
  • Share

Most Recently Shared on August 7, 2011 at 2:36 pm By:

theheart.org: trusted cardiology news and opinions

theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 9:38 pm By:

theheartorg Shelley Wood Cardiology

"Baroreflex activation" device equivocal in resistant hypertension: Rheos trial published http://dlvr.it/cqjhg

9 months ago...

Fructose can be used to induce insulin resistance and hypertension in rats. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine

greenmedinfo.com — “This article on GreenMedInfo.com concerns - Fructose-induced insulin resistance and hypertension in rats.View full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 10:39 pm By:

Exercise improves fructose-induced insulin resistance, hyperinsulinemia and hypertension. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine | Integrative Medicine

greenmedinfo.com — “This article on GreenMedInfo.com concerns - Attenuation of fructose-induced hypertension in rats by exercise training.View full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 10:33 pm By:

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

news-medical.net — “Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 12, 2011 at 6:46 am By:

Stroke_News News-Medical.Net Health News

Stroke News: FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension: Medtronic, ... http://twurl.nl/wwvm6n

9 months ago...

Medical News: ASCO: Biologic Duo Comes with OK Toxicity in Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- An intermittent schedule combining the biologic agents sorafenib (Nexavar) and bevacizumab (Avastin) in women with recurrent ovarian cancer is feasible with “manageable” adverse effects, reView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 2:33 pm By:

FightCancer FightCancer Health News

ASCO: Biologic Duo Comes with OK Toxicity in Ovarian CA http://bit.ly/kiO7L8

10 months ago...

Cardiovascular Diabetology - Latest Articles

cardiab.com — “Cardiovascular Diabetology - Latest ArticlesView full resource at cardiab.com

  • View Related
  • Share

Most Recently Shared on June 2, 2011 at 4:44 pm By:

HeartsHealth Heart Health Health News

CVD: Protein Kinase C inhibition ameliorates functional endothelial insulin resistance http://bit.ly/knE6zp Full http://bit.ly/4nbmHK

10 months ago...

Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring -- de la Sierra et al. 57 (5): 898 -- Hypertension

hyper.ahajournals.org — “Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring -- de la Sierra et al. 57 (5): 898 -- HypertensionView full resource at hyper.ahajournals.org

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 11:36 am By:

kussin49 Dr. Steven Z. Kussin Gastroenterologist, Physician, Doctor, and Internist

Doctor say blood pressure still to high? Take BP at home to be sure. 33% of patients' blood pressure high because... http://fb.me/HIK1pfnA

11 months ago...

Advertisement